2022
DOI: 10.31351/vol31iss2pp237-243
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Hepatic Enzymes in major β-thalassemic Patients using Deferasirox

Abstract: β-thalassemia major is a genetic disease that causes sever defect in normal hemoglobin synthesis. The patients with β-thalassemia major need periodic blood transfusions that can result in accumulation of body iron, so treatment with iron chelating agent is required. Complications of this iron overload affecting many vital organs, including the liver. The aim of this work was to evaluate liver enzymes in β -thalassemia major patients with deferasirox versus without it. Two groups of β-thalassemia major patients… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 18 publications
0
0
0
Order By: Relevance
“…β-thalassemia Major patients always have iron overload from inadequate erythropoiesis and recurrent blood transfusions; these patients need repeated blood transfusions to maintain a normal quality of life. (Bashi and Fathi, 2022). Iron overload may have negative effects on the heart, kidneys, lungs, liver, and endocrine system, among other vital organs.…”
Section: Introductionmentioning
confidence: 99%
“…β-thalassemia Major patients always have iron overload from inadequate erythropoiesis and recurrent blood transfusions; these patients need repeated blood transfusions to maintain a normal quality of life. (Bashi and Fathi, 2022). Iron overload may have negative effects on the heart, kidneys, lungs, liver, and endocrine system, among other vital organs.…”
Section: Introductionmentioning
confidence: 99%